The Silent Crisis Unveiled
World Haemophilia Day, observed annually on April 17th, often shines a spotlight on haemophilia as a condition primarily affecting men. However, a significant
and often overlooked issue persists: thousands of Indian women who carry the haemophilia gene are experiencing severe bleeding symptoms but are frequently misdiagnosed. The traditional medical understanding labels women as mere 'passive carriers,' but current data from the World Federation of Hemophilia reveals a stark reality: nearly 33% of individuals living with haemophilia globally are female. The Hemophilia Federation of India notes a considerable discrepancy in registered cases, suggesting that tens of thousands of symptomatic women are not officially accounted for. Experts now emphasize that approximately one in every three women carrying the haemophilia gene possesses clotting factor levels below 40%, a threshold that technically classifies them as having mild haemophilia. Haematologists are working to debunk the notion that heavy periods and easy bruising are normal, as these symptoms can signal a serious underlying condition leading to chronic fatigue, dangerous surgical risks, and persistent anaemia.
Debunking the Carrier Myth
The long-held belief that women cannot develop haemophilia is not only outdated but also biologically inaccurate. This misconception stems from a simplified understanding of X-chromosome inactivation, a complex genetic process. Dr. Vijay Ramanan, a senior consultant clinical haematologist, explains that the term 'carrier' often oversimplifies the situation. He elaborates on X-chromosome Lyonization, a random process where one of the two X chromosomes in each female cell is inactivated. If the X chromosome carrying the normal clotting gene is inactivated in a majority of cells, the defective gene then becomes more functionally dominant. This genetic lottery means a woman's carrier status is not passive; it's an active biological interplay. Consequently, a woman who is a carrier might have clotting factor levels (Factor VIII or IX) low enough to cause symptoms comparable to mild or even moderate haemophilia. Many women labelled as 'carriers' may, in fact, experience significant bleeding tendencies and require medical attention similar to male haemophilia patients.
Normalizing Heavy Periods
In India, a significant obstacle to diagnosing bleeding disorders in women is cultural normalization. Heavy menstrual bleeding is often dismissed within families as a typical hereditary trait rather than a critical medical warning sign. Dr. Ramanan points out that while heavy periods are common, specific clinical indicators differentiate them from a serious disorder. He highlights that needing to change pads or tampons every hour for several consecutive hours is not considered normal menstrual flow. Other red flags include menstrual bleeding persisting for more than seven days, passing large blood clots (exceeding 2–2.5 cm), and the necessity of using double protection to manage the flow. These symptoms, when overlooked or normalized, can delay crucial medical intervention for underlying bleeding disorders.
Gynaecology vs. Haematology Gap
When women present with symptoms like heavy menstrual bleeding, they often encounter a diagnostic loop. Their primary symptom typically leads them to gynaecologists, who may focus on structural uterine issues such as fibroids or cysts, inadvertently overlooking the underlying blood chemistry. Dr. Kunal Sehgal, managing director and chief pathologist, observes this disconnect frequently. He notes that many women undergo numerous ultrasounds or hormonal therapies without improvement because a fundamental haemostasis evaluation is missed. Bleeding issues are not always uterine-related; mild clotting factor deficiencies or platelet function abnormalities can manifest solely as heavy menstrual bleeding and are undetectable via imaging. Dr. Sehgal advocates for enhanced collaboration between gynaecologists and haematology-focused diagnostics to prevent years of misdirected treatment and ensure accurate diagnosis.
The Burden of Anaemia
Living with an undiagnosed bleeding disorder imposes a continuous burden of exhaustion. Excessive bleeding each month leads to a chronic depletion of the body's iron reserves, resulting in a condition known as functional anaemia. Dr. Sehgal explains that persistent, undiagnosed bleeding causes ongoing iron loss, creating a significant, silent energy deficit. While the body might adapt, it does so at a considerable cost. Simply administering iron supplements offers only temporary relief if the root cause of the bleeding isn't addressed. Dr. Chandrakant Lahane, a consultant haematologist, emphasizes the cognitive impact of this persistent state. Individuals suffering from functional anaemia, though undiagnosed, experience impaired cognitive function and reduced work capacity. This leaves women technically functioning but living with constant fatigue, low stamina, and compromised physical health.
Surgical Risks Revealed
The most precarious situations for undiagnosed women with bleeding tendencies often arise during routine surgical procedures. Without a known history of a bleeding disorder, interventions such as C-sections, gallbladder removals, or even simple tooth extractions can escalate into life-threatening emergencies. Dr. Sehgal warns that undiagnosed bleeding issues can complicate even minor operations, with mild disorders sometimes presenting normal results in routine tests. This lack of recognition increases the risk of spontaneous bleeding, delayed healing, and the potential need for blood transfusions. Dr. Ramanan adds that bleeding can manifest not immediately, but hours or even days post-procedure, making it significantly more dangerous and challenging to manage.
Self-Audit for Haemophilia
Given that symptoms in women can be subtle, mucocutaneous (affecting skin and mucous membranes), or differ from the joint bleeds typically seen in men, a proactive self-assessment of one's medical history is crucial. Dr. Ramanan provides a checklist of indicators that necessitate a specialized haematological evaluation. These include experiencing extremely heavy first periods (menarche) requiring hospitalization or transfusion, frequent nosebleeds, prolonged bleeding after minor cosmetic procedures like threading or waxing, easy bruising from minimal impact, extended bleeding after dental work, and excessive blood loss following a miscarriage or childbirth (postpartum haemorrhage). Recognizing these signs empowers women to seek appropriate medical attention and bridge the gap between perceived normalcy and the need for expert haematological assessment.
Beyond Basic Lab Tests
A significant hurdle in the diagnostic pathway for women is the over-reliance on standard blood tests, which often appear normal. Many women are informed their blood work is unremarkable because physicians limit their investigation to basic screenings like bleeding time (BT) and clotting time (CT). Dr. Ramanan clarifies that these tests are frequently inadequate for ruling out haemophilia or related disorders, as they can yield normal results even in individuals with mild to moderate conditions. To achieve a definitive diagnosis, women should specifically request advanced tests. These include specific factor assays to measure Factor VIII and Factor IX levels, von Willebrand Factor (vWF) testing, and comprehensive coagulation profiles, which encompass PT/INR and aPTT. These more detailed analyses are essential for accurately identifying bleeding tendencies.
Advocating with Language
To overcome medical scepticism and ensure proper investigation, experts recommend that women employ precise, clinical terminology when discussing their symptoms with healthcare providers. Dr. Lahane advises using phrases like 'excessive menstrual bleeding' instead of merely 'heavy periods,' and terms such as 'mucosal bleeding,' 'easy bruising,' and 'tendency to bleed.' Mentioning specific disorders like haemophilia and von Willebrand disease can also prompt further inquiry. Dr. Ramanan concurs, stating that explicitly requesting a 'coagulation workup including factor assays' signals to the doctor that the patient is informed and requires a more thorough evaluation beyond superficial symptom assessment. This informed communication is vital for driving appropriate diagnostic pathways.
Safe Medications List
For women with suspected or confirmed bleeding tendencies, careful consideration of medication is paramount, as many common over-the-counter (OTC) painkillers can exacerbate bleeding by affecting platelet function. Dr. Lahane cautions that pain relievers like Aspirin and Ibuprofen (NSAIDs) can increase blood loss. He provides a list of safer alternatives for pain and fever management. Paracetamol is generally considered safe. For managing heavy bleeding, Tranexamic acid can be prescribed by a haematologist. Hormonal therapies can also be beneficial for menstrual regulation, but these should only be used under the combined supervision of both a gynaecologist and a haematologist, ensuring a coordinated approach to care and minimizing risks.
Family Screening Imperative
Experts strongly advocate for diagnosis to extend to a family context, particularly if a male relative is diagnosed with haemophilia. This necessitates a ripple effect of screening for female relatives, including mothers, sisters, and daughters, even in the absence of apparent symptoms. Dr. Ramanan emphasizes that early identification allows for better preparedness during surgeries, childbirth, or other medical interventions, ensuring that appropriate precautions are in place. World Haemophilia Day serves as a crucial reminder that healthcare must be equitable. By moving beyond the outdated 'carrier' label and acknowledging the symptomatic woman, the medical community can finally provide these overlooked patients with the life-saving care they have long deserved.
